triamcinolonacetonid "2care4" 40 mg/ml injektionsvæske, suspension
2care4 aps - triamcinolonacetonid - injektionsvæske, suspension - 40 mg/ml
triamcinolonacetonid "orifarm" 40 mg/ml injektionsvæske, suspension
orifarm a/s - triamcinolonacetonid - injektionsvæske, suspension - 40 mg/ml
eslicarbazepinacetat "nordic prime" 800 mg tabletter
nordic prime aps - eslicarbazepinacetat - tabletter - 800 mg
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - prophylax af influenza i en officielt erklæret pandemisk situation. pandemic influenza vaccine bør anvendes i overensstemmelse med officielle retningslinjer.
solifenacin "aristo" 10 mg filmovertrukne tabletter
aristo pharma gmbh - solifenacinsuccinat - filmovertrukne tabletter - 10 mg
solifenacin "aristo" 5 mg filmovertrukne tabletter
aristo pharma gmbh - solifenacinsuccinat - filmovertrukne tabletter - 5 mg
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
solifenacinsuccinat/tamsulosinhydrochlorid "aristo" 6+0,4 mg tabletter med modificeret udløsning
aristo pharma gmbh - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg
solifenacinsuccinat/tamsulosinhydrochlorid "heumann" 6+0,4 mg tabletter med modificeret udløsning
heumann pharma gmbh & co. generica kg - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg
solifenacinsuccinat/tamsulosinhydrochlorid "rafarm" 6+0,4 mg tabletter med modificeret udløsning
rafarm s.a. - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg